AI-Powered Drug and Biomarker Discovery Using Multi-Modal Image Data

29 Jan 2026
AI In Drug Discovery Stage
  • Role of the tumour microenvironment – Understanding how spatial organisation of different cell types and their interactions drive cancer progression and resistance. 

  • Explainable deep learning with graph neural networks – Developing graph-based models to reveal tumour heterogeneity and microenvironmental features and identify target cellular populations 

  • Application in drug and biomarker discovery – Applying these methods to multiplexed imaging and exploring their potential for identifying therapeutic targets and informing drug development. 

Speakers
Heba Sailem
Heba Sailem,  Head of Biomedical AI - King's College London